Icagen News (NASDAQ:ICGN)
| Latest Icagen News Headlines | | Date | Time | Source | | | 07/29/2008 | 7:30AM | PRNUS | Icagen to Report Second Quarter 2008 Results and Conduct Conference Call on August 5, 2008
RESEARCH TRIANGLE PARK, N.C., July 29 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today announced it will release second quarter 2008 financial results on Tuesday, August 5, 2008. The Company will also conduct a conference call that day at 10:00 a.m. Eastern Time to discuss results and highlights of the second... More...>> |
| 12/12/2005 | 4:30PM | PRNUS | Alexandria Real Estate Equities, Inc. Announces the Appointment of Martin A. Simonetti to the Company's Board of Directors
PASADENA, Calif., Dec. 12 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced that its Board of Directors appointed Martin A. Simonetti as a director to serve until the 2006 annual meeting of stockholders of the Company. Mr. Simonetti will also serve as a member of the Audit Committee of... More...>> |
| 11/04/2005 | 8:49AM | PRNUS | Icagen Reports Third Quarter 2005 Financial Results
RESEARCH TRIANGLE PARK, N.C., Nov. 4 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today reported financial results for the third quarter ended September 30, 2005. Revenues for the third quarter of 2005 totaled $2.3 million. Net loss for the third quarter of 2005 was $4.8 million. As of September 30, 2005... More...>> |
| 11/01/2005 | 5:54PM | PRNUS | Icagen to Present at Two Upcoming Conferences
RESEARCH TRIANGLE PARK, N.C., Nov. 1 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today announced that P. Kay Wagoner, Ph.D., Chief Executive Officer, will present at the following conferences:
* CIBC 16th Annual Healthcare Conference at the Waldorf-Astoria Hotel in
New York City on Monday November 7th... More...>> |
| 10/27/2005 | 9:00AM | PRNUS | Icagen Announces Third Quarter 2005 Financial Results Conference Call
RESEARCH TRIANGLE PARK, N.C., Oct. 27 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today announced it will host a conference call to discuss the Company's third quarter 2005 financial results on Friday, November 4, 2005 at 10:00 am ET. The call will follow the release of the third quarter 2005 financial results... More...>> |
| 09/19/2005 | 9:00AM | PRNUS | Icagen to Present at the 2005 UBS Global Life Sciences Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 19 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today announced that P. Kay Wagoner, Ph.D., Chief Executive Officer, will present at the 2005 UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City on Monday, September 26th at 2:00 p.m. ET.
About Icagen
Icagen... More...>> |
| 08/09/2005 | 8:30AM | PRNUS | Icagen Reports Second Quarter 2005 Financial Results
RESEARCH TRIANGLE PARK, N.C., Aug. 9 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today reported financial results for the second quarter ended June 30, 2005. Revenues for the second quarter of 2005 totaled $1.7 million. Net loss for the second quarter of 2005 was $4.9 million. As of June 30, 2005, cash and... More...>> |
| 08/02/2005 | 1:23PM | PRNUS | Icagen Announces Second Quarter 2005 Financial Results Conference Call
RESEARCH TRIANGLE PARK, N.C., Aug. 2 /PRNewswire-FirstCall/ -- Icagen, Inc. (NASDAQ:ICGN) today announced it will host a conference call to discuss the Company's second quarter 2005 financial results on Tuesday, August 9, 2005 at 10:00 am Eastern Standard Time. The call will follow the release of the second quarter... More...>> |
| 05/18/2005 | 4:50PM | PRNUS | Icagen to Present at the Annual UBS Global Pharmaceuticals Conference
Icagen to Present at the Annual UBS Global Pharmaceuticals
Conference
RESEARCH TRIANGLE PARK, N.C., May 18 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced that Richard D. Katz, M.D., Chief Financial
Officer, will present at the Annual UBS Global Pharmaceuticals Conference at
the Grand Hyatt Hotel... More...>> |
| 05/13/2005 | 8:30AM | PRNUS | Icagen Reports First Quarter 2005 Financial Results
Icagen Reports First Quarter 2005 Financial Results
RESEARCH TRIANGLE PARK, N.C., May 13 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today reported financial results for the first quarter ended
March 31, 2005. For the first quarter of 2005, net loss increased to $5.3
million from $4.1 million for the first... More...>> |
| 05/06/2005 | 9:43AM | PRNUS | Icagen Announces First Quarter 2005 Financial Results Conference Call
Icagen Announces First Quarter 2005 Financial Results Conference
Call
RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced it will host a conference call to discuss the
Company's first quarter 2005 financial results on Friday, May 13, 2005 at 10:00
am Eastern Standard... More...>> |
| 03/30/2005 | 4:15PM | PRNUS | Icagen to Present at the Annual CIBC Biotechnology & Specialty Pharmaceuticals Conference
Icagen to Present at the Annual CIBC Biotechnology & Specialty
Pharmaceuticals Conference
RESEARCH TRIANGLE PARK, N.C., March 30 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced that P. Kay Wagoner, Ph.D., Chief Executive
Officer, will present at the Annual CIBC Biotechnology & Specialty
Pharmaceuticals... More...>> |
| 03/30/2005 | 8:30AM | PRNUS | Icagen Reports Fourth Quarter and Full Year 2004 Financial Results and Reports Results of Phase Ib Clinical Trial of ICA-69673
Icagen Reports Fourth Quarter and Full Year 2004 Financial
Results and Reports Results of Phase Ib Clinical Trial of ICA-69673
RESEARCH TRIANGLE PARK, N.C., March 30 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) reported today its financial results for the fourth quarter and
year ended December 31, 2004. For... More...>> |
| 03/16/2005 | 9:01AM | PRNUS | Icagen Announces the Appointment of Martin Simonetti to the Company's Board of Directors
Icagen Announces the Appointment of Martin Simonetti to the
Company's Board of Directors
RESEARCH TRIANGLE PARK, N.C., March 16 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced the appointment of Martin Simonetti to its Board
of Directors. Mr. Simonetti is currently the Chief Financial Officer of
Dendreon... More...>> |
| 03/15/2005 | 9:00AM | PRNUS | Icagen Receives Milestone Payment From Yamanouchi Pharmaceutical Co., Ltd.
Icagen Receives Milestone Payment From Yamanouchi Pharmaceutical
Co., Ltd.
RESEARCH TRIANGLE PARK, N.C., March 15 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced that it has received a milestone payment from
Yamanouchi Pharmaceutical Co., Ltd. ("Yamanouchi") related to the selection of
a compound... More...>> |
| 03/10/2005 | 9:34AM | PRNUS | Icagen Announces Underwriters' Purchase of 100,000 Shares of Common Stock Pursuant to Over-Allotment Option
Icagen Announces Underwriters' Purchase of 100,000 Shares of
Common Stock Pursuant to Over-Allotment Option
RESEARCH TRIANGLE PARK, N.C., March 10 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced that the underwriters of its recent initial
public offering of 5,000,000 shares of common stock have... More...>> |
| 02/22/2005 | 8:57AM | PRNUS | Icagen Initiates Enrollment in Pivotal Phase III Trial of ICA-17043 for the Treatment of Sickle Cell Disease
Icagen Initiates Enrollment in Pivotal Phase III Trial of
ICA-17043 for the Treatment of Sickle Cell Disease
RESEARCH TRIANGLE PARK, N.C., Feb. 22 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced the initiation of enrollment in its pivotal Phase
III trial of ICA-17043 for the treatment of sickle... More...>> |
| 02/03/2005 | 10:33AM | PRNUS | Icagen, Inc. Announces Its Initial Public Offering
Icagen, Inc. Announces Its Initial Public Offering
RESEARCH TRIANGLE PARK, N.C., Feb. 3 /PRNewswire-FirstCall/ -- Icagen, Inc.
(NASDAQ:ICGN) today announced the pricing of its initial public offering of
5,000,000 shares of its common stock at a price of $8.00 per share. All of the
shares are being sold by Icagen... More...>> |
|
|
|